trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Kong Q et al. Telomere elongation facilitated by trichostatin a in cloned embryos and pigs by somatic cell nuclear transfer. 2014 Stem Cell Rev pmid:24510582
Brglez V et al. Secreted phospholipases Aâ‚‚are differentially expressed and epigenetically silenced in human breast cancer cells. 2014 Biochem. Biophys. Res. Commun. pmid:24508801
Sharifulina SA et al. Epigenetic regulation of death of crayfish glial cells but not neurons induced by photodynamic impact. 2014 Brain Res. Bull. pmid:24502940
Yang W et al. Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer's disease. 2014 Life Sci. pmid:24486299
Li Z et al. DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. 2015 Gastric Cancer pmid:24481854
Michalak P Evidence for maternal imprinting of 45S ribosomal RNA genes in Xenopus hybrids. 2014 Dev. Genes Evol. pmid:24477594
Karki P et al. Yin Yang 1 is a repressor of glutamate transporter EAAT2, and it mediates manganese-induced decrease of EAAT2 expression in astrocytes. 2014 Mol. Cell. Biol. pmid:24469401
Smith S et al. Histone deacetylase inhibitors selectively target homology dependent DNA repair defective cells and elevate non-homologous endjoining activity. 2014 PLoS ONE pmid:24466340
Sassi Fde A et al. Inhibitory activities of trichostatin a in U87 glioblastoma cells and tumorsphere-derived cells. 2014 J. Mol. Neurosci. pmid:24464841
Li H et al. The histone deacetylase inhibitor trichostatin a promotes totipotency in the male gametophyte. 2014 Plant Cell pmid:24464291
Xiao W et al. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition in retinal pigment epithelium cells. 2014 J. Cell. Mol. Med. pmid:24456602
Kumar P et al. Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-a gene: interactive roles of modified histones, histone acetyltransferase, p300, AND Sp1. 2014 J. Biol. Chem. pmid:24451378
Oride A et al. Trichostatin A specifically stimulates gonadotropin FSHβ gene expression in gonadotroph LβT2 cells. 2014 Endocr. J. pmid:24430728
Poljak M et al. Class I to III histone deacetylases differentially regulate inflammation-induced matrix metalloproteinase 9 expression in primary amnion cells. 2014 Reprod Sci pmid:24429678
Sugimoto K et al. Improving allogeneic islet transplantation by suppressing Th17 and enhancing Treg with histone deacetylase inhibitors. 2014 Transpl. Int. pmid:24410777
Sathe A et al. MicroRNA let-7f: a novel regulator of innate immune response in human endocervical cells. 2014 Am. J. Reprod. Immunol. pmid:24405266
Xie M et al. Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. 2014 Circulation pmid:24396039
Yoshida M et al. Effects of trichostatins on differentiation of murine erythroleukemia cells. 1987 Cancer Res. pmid:2439196
Koriyama Y et al. Neuritogenic activity of trichostatin A in adult rat retinal ganglion cells through acetylation of histone H3 lysine 9 and RARβ induction. 2014 J. Pharmacol. Sci. pmid:24389816
Mahmud N et al. Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells. 2014 Biol. Blood Marrow Transplant. pmid:24374212
Alcarraz-Vizán G et al. Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma metabolic reprogramming: trichostatin A as a case study. 2014 Biochim. Biophys. Acta pmid:24368265
Tian Y et al. Ubiquitin B in cervical cancer: critical for the maintenance of cancer stem-like cell characters. 2013 PLoS ONE pmid:24367661
Zhu M et al. Histone decacetylase inhibitors prevent mitochondrial fragmentation and elicit early neuroprotection against MPP+. 2014 CNS Neurosci Ther pmid:24351065
Liu J et al. DNA promoter and histone H3 methylation downregulate NGX6 in gastric cancer cells. 2014 Med. Oncol. pmid:24338274
Hou SY et al. Expressions of MAGE-A9 and MAGE-A11 in breast cancer and their expression mechanism. 2014 Arch. Med. Res. pmid:24316396
Han B et al. Trichostatin A stabilizes the expression of pluripotent genes in human mesenchymal stem cells during ex vivo expansion. 2013 PLoS ONE pmid:24312356
Serrat N et al. The response of secondary genes to lipopolysaccharides in macrophages depends on histone deacetylase and phosphorylation of C/EBPβ. 2014 J. Immunol. pmid:24307736
Krause M et al. Probing the compressibility of tumor cell nuclei by combined atomic force-confocal microscopy. 2013 Phys Biol pmid:24304807
Shim SH et al. Histone deacetylase inhibitors suppress coxsackievirus B3 growth in vitro and myocarditis induced in mice. 2013 Acta Virol. pmid:24294962
Katsuno M et al. [Dysfunction of dynactin 1 in motor neuron degeneration]. 2013 Rinsho Shinkeigaku pmid:24291886
Holownia A et al. Histone acetylation and arachidonic acid cytotoxicity in HepG2 cells overexpressing CYP2E1. 2014 Naunyn Schmiedebergs Arch. Pharmacol. pmid:24287576
Green BB and Kerr DE Epigenetic contribution to individual variation in response to lipopolysaccharide in bovine dermal fibroblasts. 2014 Vet. Immunol. Immunopathol. pmid:24268632
Unland R et al. Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system. 2014 J. Neurooncol. pmid:24264533
Shin HJ et al. Histone deacetylase classes I and II regulate Kaposi's sarcoma-associated herpesvirus reactivation. 2014 J. Virol. pmid:24227836
Liu Y et al. Expression loss and revivification of RhoB gene in ovary carcinoma carcinogenesis and development. 2013 PLoS ONE pmid:24223801
Jagirdar K et al. The NR4A2 nuclear receptor is recruited to novel nuclear foci in response to UV irradiation and participates in nucleotide excision repair. 2013 PLoS ONE pmid:24223135
Frame FM et al. HDAC inhibitor confers radiosensitivity to prostate stem-like cells. 2013 Br. J. Cancer pmid:24220693
Chandwani S et al. Induction of DARPP-32 by brain-derived neurotrophic factor in striatal neurons in vitro is modified by histone deacetylase inhibitors and Nab2. 2013 PLoS ONE pmid:24204683
Busbee PB et al. Natural indoles, indole-3-carbinol and 3,3'-diindolymethane, inhibit T cell activation by staphylococcal enterotoxin B through epigenetic regulation involving HDAC expression. 2014 Toxicol. Appl. Pharmacol. pmid:24200994
Seo J et al. Trichostatin A epigenetically increases calpastatin expression and inhibits calpain activity and calcium-induced SH-SY5Y neuronal cell toxicity. 2013 FEBS J. pmid:24200051
Liesz A et al. Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. 2013 J. Neurosci. pmid:24174668
Kim TW et al. Nuclear-encoded mitochondrial MTO1 and MRPL41 are regulated in an opposite epigenetic mode based on estrogen receptor status in breast cancer. 2013 BMC Cancer pmid:24160266
Chen X et al. The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition of lens epithelial cells. 2013 Cell Death Dis pmid:24157878
Peng L et al. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro]. 2013 Nan Fang Yi Ke Da Xue Xue Bao pmid:24144739
Xu M et al. Histone deacetylase inhibitors induce human renal cell carcinoma cell apoptosis through p-JNK activation. 2013 Nan Fang Yi Ke Da Xue Xue Bao pmid:24144737
Mathiyalagan P et al. The primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heart. 2014 Nucleic Acids Res. pmid:24137001
Yamamura A et al. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. 2013 Biochem. Biophys. Res. Commun. pmid:24134849
He G et al. Inhibition of autophagy induced by TSA sensitizes colon cancer cell to radiation. 2014 Tumour Biol. pmid:24122231
Zutz C et al. Small chemical chromatin effectors alter secondary metabolite production in Aspergillus clavatus. 2013 Toxins (Basel) pmid:24105402
Moldrich RX et al. Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice. 2013 Behav. Brain Res. pmid:24103642